12:16 PM EST - Lorus Therapeutics Inc. : battered shares gained more than 8 percent Wednesday after the company said it has received a patent in Mexico related to the cancer drug Virulizin and published two research studies on the treatment. Lorus Therapeutics Inc.
shares T.LOR are trading unchanged at $0.12.
